JLJustin Lee

Justin Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Justin Lee has a total of 213 co-authors. Here are the top co-authors by number of shared publications:

  • Keith Michael Channon

    Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK

    7 shared publications
  • Matthew D. Robson

    Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Department of Medicine University of Oxford Oxford UK

    6 shared publications
  • Stefan Neubauer

    6 shared publications
  • Saurabh Kumar

    Alfred Heart Centre, Alfred Hospital, Melbourne, VIC, Australia Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia Department of Cardiology, Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, University of Melbourne, Parkville, VIC, Australia

    5 shared publications
  • Cheerag Shirodaria

    From the Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK

    4 shared publications
  • Joseph B. Morton

    Department of Cardiology, Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, University of Melbourne, Parkville, VIC, Australia Melbourne Private Hospital, Parkville, VIC, Australia

    4 shared publications

Latest Publications

  • Open Access

    Long-term Survival and Stroke after Cardiac Surgery with Concomitant Surgical Ablation for Atrial Fibrillation

    by Mark A Sammut, Justin Lee, Sxe Chang Cheong, Chai Jin Lim, Manwi Singh, Robert F Storey, Peter C Braidley, Norman P Briffa, Neil Cartwright, Govind Chetty, et al.

    Background: Concomitant surgical ablation (SA) is recommended at the time of cardiac surgery in patients with AF but it remains widely underperformed. We sought to report on the safety and long-term efficacy of concomitant SA and the associated incidence of stroke and survival. Methods: A retrospective observational study was performed on patients with AF undergoing cardiac surgery between April 2011 and March 2022 with grouping based on whether or not they received concomitant SA. Thirty-day complications and long-term atrial tachyarrhythmia recurrence, stroke and mortality were compared between groups after propensity score matching. Results: A total of 1,205 patients were included; two groups were obtained after matching (n=326 each). Post-operative length of stay was slightly longer in matched patients receiving concomitant SA (median 10 versus 9 days; p=0.048) but length of stay on intensive care and complication rates were similar in both groups. Freedom from atrial tachyarrhythmia in the SA group was 74% at 1 year and 58% at 3 years compared with 10% and 8%, respectively, for the no-SA group. Ten-year survival was increased for matched patients in the SA group compared with patients in the no-SA group (adjusted HR 0.61; 95% CI [0.45–0.82]; p=0.001) but the incidence of ischaemic stroke was similar (subdistribution HR 1.11; 95% CI [0.53–2.30]; p=0.790). Conclusion: In patients with AF undergoing cardiac surgery, concomitant SA was associated with improved long-term survival without increasing complications. Concomitant SA was not associated with an independent reduction in the long-term incidence of ischaemic stroke.


  • Open Access

    Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function

    by Martijn H. van der Ree, Wiert F. Hoeksema, Adrian Luca, Jorrit Visser, Brian V. Balgobind, Michiel Zumbrink, Raymond Spier, Claudia Herrera-Siklody, Justin Lee, Matthew Bates, et al.


  • Open Access

    Treatment of pathophysiologic propagation outside of the pulmonary veins in retreatment of atrial fibrillation patients: RECOVER AF study

    by Timothy R Betts, Wilson W Good, Lea Melki, Andreas Metzner, Andrew Grace, Atul Verma, Stephen Murray, Simon James, Tom Wong, Lucas V A Boersma, et al.

    RECOVER AF evaluated the performance of whole-chamber non-contact charge-density mapping to guide the ablation of non-pulmonary vein (PV) targets in persistent atrial fibrillation (AF) patients following either a first or second failed procedure. RECOVER AF was a prospective, non-randomized trial that enrolled patients scheduled for a first or second ablation retreatment for recurrent AF. The PVs were assessed and re-isolated if necessary. The AF maps were used to guide the ablation of non-PV targets through elimination of pathologic conduction patterns (PCPs). Primary endpoint was freedom from AF on or off antiarrhythmic drugs (AADs) at 12 months. Patients undergoing retreatment with the AcQMap System (n = 103) were 76% AF-free at 12 months [67% after single procedure (SP)] on or off AADs (80% free from AF on AADs). Patients who had only received a pulmonary vein isolation (PVI) prior to study treatment of non-PV targets with the AcQMap System were 91% AF-free at 12 months (83% SP). No major adverse events were reported. Non-contact mapping can be used to target and guide the ablation of PCPs beyond the PVs in persistent AF patients returning for a first or second retreatment with 76% freedom from AF at 12 months. The AF freedom was particularly high, 91% (43/47), for patients enrolled having only a prior de novo PVI, and freedom from all atrial arrhythmias for this cohort was 74% (35/47). These early results are encouraging and suggest that guiding individualized targeted ablation of PCPs may therefore be advantageous to target at the earliest opportunity in patients with persistent AF.


  • Open Access

    Interobserver Variability in Target Definition for Stereotactic Arrhythmia Radioablation

    by Martijn H. van der Ree, Phillip S. Cuculich, Marcel van Herk, Geoffrey D. Hugo, Jippe C. Balt, Matthew Bates, Gordon Ho, Etienne Pruvot, Claudia Herrera-Siklody, Wiert F. Hoeksema, et al.

    Background Stereotactic arrhythmia radioablation (STAR) is emerging as a potential new therapy for patients with refractory ventricular tachycardia (VT). The arrhythmogenic substrate (target) is synthesized from clinical and electro-anatomical information. This study was designed to evaluate the baseline interobserver variability in target delineation for STAR. Methods Delineation software designed for research purposes was used. The study was split into three phases. Firstly, electrophysiologists (observers) delineated a well-defined structure in three patients (spinal canal). Secondly, observers delineated the arrhythmogenic cardiac VT target in three patients previously treated with STAR based on case descriptions. To evaluate baseline performance, a basic workflow approach was used, no advanced techniques were allowed (e.g. image integration). Thirdly, observers delineated three predefined segments from the cardiac 17-segment model. Interobserver variability was evaluated by assessing volumes, variation in distance to the median volume as expressed by the root-mean-square of the observer standard deviation (RMS SD) over the target volume, and the Dice coefficient. Results Ten electrophysiologists completed the study. For the first phase (spinal canal delineation), interobserver variability was low as indicated by low variation in distance to the median volume (RMS SD range: 0.02-0.02cm) and high Dice coefficients (mean: 0.97±0.01). In the second phase (VT-target delineation), distance to the median volume was large (RMS SD range: 0.52-1.02cm) and the Dice coefficients low (mean: 0.40±0.15). In the third phase (segment delineation), similar results were observed (RMS SD range: 0.51-1.55cm, Dice coefficient mean: 0.31±0.21) Conclusions Interobserver variability is high for manual delineation of the VT-target and ventricular segments. Difficulties in cardiac anatomical orientation on traditional radiation oncology CT scans appear to be an important driver of variability. This evaluation of the baseline observer variation shows that there is a need for methods and tools to improve variability and allows for future comparison of interventions aiming to reduce observer variation.

  • Open Access

    Characterization of persistent atrial fibrillation with non‐contact charge density mapping and relationship to voltage

    by Justin M. S. Lee, Thomas A. Nelson, Richard H. Clayton, Nicholas F. Kelland

    Background: Despite studies using localized high density contact mapping and lower resolution panoramic approaches, the mechanisms that sustain human persistent atrial fibrillation (AF) remain unresolved. Voltage mapping is commonly employed as a surrogate of atrial substrate to guide ablation procedures.Objective: To study the distribution and temporal stability of activation during persistent AF using a global non‐contact charge density approach and compare the findings with bipolar contact mapping.Methods: Patients undergoing either redo or de novo ablation for persistent AF underwent charge density and voltage mapping to guide the ablation procedure. Offline analysis was performed to measure the temporal stability of three specific charge density activation (CDA) patterns, and the degree of spatial overlap between CDA patterns and low voltage regions.Results: CDA was observed in patient‐specific locations that partially overlapped, comprising local rotational activity (18% of LA), local irregular activity (41% of LA), and focal activity (39% of LA). Local irregular activity had the highest temporal stability. LA voltage was similar in regions with and without CDA.Conclusion: In persistent AF, CDA patterns appear unrelated to low voltage areas but occur in varying locations with high temporal stability.


  • Open Access

    Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience

    by Justin Lee, Matthew Bates, Ewen Shepherd, Stephen Riley, Michael Henshaw, Peter Metherall, Jim Daniel, Alison Blower, David Scoones, Michele Wilkinson, et al.

    Background Options for patients with ventricular tachycardia (VT) refractory to antiarrhythmic drugs and/or catheter ablation remain limited. Stereotactic radiotherapy has been described as a novel treatment option. Methods Seven patients with recurrent refractory VT, deemed high risk for either first time or redo invasive catheter ablation, were treated across three UK centres with non-invasive cardiac stereotactic ablative radiotherapy (SABR). Prior catheter ablation data and non-invasive mapping were combined with cross-sectional imaging to generate radiotherapy plans with aim to deliver a single 25 Gy treatment. Shared planning and treatment guidelines and prospective peer review were used. Results Acute suppression of VT was seen in all seven patients. For five patients with at least 6 months follow-up, overall reduction in VT burden was 85%. No high-grade radiotherapy treatment-related side effects were documented. Three deaths (two early, one late) occurred due to heart failure. Conclusions Cardiac SABR showed reasonable VT suppression in a high-risk population where conventional treatment had failed.


  • MA-SOCRATIS: An automatic pipeline for robust segmentation of the left ventricle and scar

    by Michail Mamalakis, Pankaj Garg, Tom Nelson, Justin Lee, Jim M. Wild, Richard H. Clayton


  • INFLUENCE OF ENDURANCE SPORTS ON ATRIAL FIBRILLATION ABLATION OUTCOMES

    by Michael Liu, Justin Lee, Lindsay Klooster, Luis Scott

  • Open Access

    Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series

    by Mark T Mills, Thomas A Nelson, Nicholas F Kelland, Jonathan Sahu, Justin Lee, Nigel Lewis, Tarekegn Hiwot, Andreas L Kyriacou

    Background: Cardiac involvement in Anderson–Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is limited.Case summary: We discuss RFA of drug-refractory VT electrical storm in three males with AFD. The first patient (53 years old) had extensive involvement of the inferolateral left ventricle (LV) demonstrated with cardiac magnetic resonance imaging (CMRI), with a left ventricular ejection fraction (LVEF) of 35%. Two VT ablation procedures were performed. At the first procedure, the inferobasal endocardial LV was ablated. Furthermore, VT prompted a second ablation, where epicardial and endocardial sites were ablated. The acute arrhythmia burden was controlled but he died 4 months later despite appropriate implantable cardioverter-defibrillator therapies for VT. The second patient (67 years old) had full-thickness inferolateral involvement demonstrated with CMRI and LVEF of 45%. RFA of several endocardial left ventricular sites was performed. Over a 3-year follow-up, only brief non-sustained VT was identified, but he subsequently died of cardiac failure. Our third patient (69 years old), had an LVEF of 35%. He had RFA of endocardial left ventricular apical disease, but died 3 weeks later of cardiac failure.Discussion: RFA of drug-refractory VT in AFD is feasible using standard electrophysiological mapping and ablation techniques, although the added clinical benefit is of questionable value. VT storm in the context of AFD may be a marker of end-stage disease.